668 related articles for article (PubMed ID: 15457444)
21. Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.
Dervieux T; Kremer J; Lein DO; Capps R; Barham R; Meyer G; Smith K; Caldwell J; Furst DE
Pharmacogenetics; 2004 Nov; 14(11):733-9. PubMed ID: 15564880
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
Salazar J; Moya P; Altés A; Díaz-Torné C; Casademont J; Cerdà-Gabaroi D; Corominas H; Baiget M
Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201
[TBL] [Abstract][Full Text] [Related]
23. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
[TBL] [Abstract][Full Text] [Related]
24. Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.
Yamamoto T; Shikano K; Nanki T; Kawai S
Sci Rep; 2016 Oct; 6():35615. PubMed ID: 27752107
[TBL] [Abstract][Full Text] [Related]
25. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.
Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R
Biomed Res Int; 2014; 2014():368681. PubMed ID: 24967362
[TBL] [Abstract][Full Text] [Related]
26. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.
Shih C; Chen VJ; Gossett LS; Gates SB; MacKellar WC; Habeck LL; Shackelford KA; Mendelsohn LG; Soose DJ; Patel VF; Andis SL; Bewley JR; Rayl EA; Moroson BA; Beardsley GP; Kohler W; Ratnam M; Schultz RM
Cancer Res; 1997 Mar; 57(6):1116-23. PubMed ID: 9067281
[TBL] [Abstract][Full Text] [Related]
27. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
[TBL] [Abstract][Full Text] [Related]
28. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
29. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
[TBL] [Abstract][Full Text] [Related]
30. Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis.
Dervieux T; Wessels JA; Kremer JM; Padyukov L; Seddighzadeh M; Saevarsdottir S; van Vollenhoven RF; Klareskog L; Huizinga TW; Guchelaar HJ
Pharmacogenet Genomics; 2012 Jan; 22(1):1-9. PubMed ID: 22044941
[TBL] [Abstract][Full Text] [Related]
31. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
Wessels JA; van der Kooij SM; le Cessie S; Kievit W; Barerra P; Allaart CF; Huizinga TW; Guchelaar HJ;
Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
[TBL] [Abstract][Full Text] [Related]
32. ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients.
Kurzawski M; Malinowski D; Szarmach N; Nowak A; Goryniak A; Pawlik A; Droździk M
Pharmacogenomics; 2016 Dec; 17(18):1971-1978. PubMed ID: 27885916
[TBL] [Abstract][Full Text] [Related]
33. Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.
Wolf J; Stranzl T; Filipits M; Pohl G; Pirker R; Leeb B; Smolen JS
Ann Rheum Dis; 2005 Apr; 64(4):564-8. PubMed ID: 15345497
[TBL] [Abstract][Full Text] [Related]
34. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639
[TBL] [Abstract][Full Text] [Related]
35. The effect of methotrexate and 7-hydroxymethotrexate on rat adjuvant arthritis and on urinary aminoimidazole carboxamide excretion.
Baggott JE; Morgan SL; Koopman WJ
Arthritis Rheum; 1998 Aug; 41(8):1407-10. PubMed ID: 9704638
[TBL] [Abstract][Full Text] [Related]
36. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
[TBL] [Abstract][Full Text] [Related]
37. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
38. The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
Becker ML; Gaedigk R; van Haandel L; Thomas B; Lasky A; Hoeltzel M; Dai H; Stobaugh J; Leeder JS
Arthritis Rheum; 2011 Jan; 63(1):276-85. PubMed ID: 20954192
[TBL] [Abstract][Full Text] [Related]
39. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
[TBL] [Abstract][Full Text] [Related]
40. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
Muralidharan N; Mariaselvam CM; Jain VK; Gulati R; Negi VS
Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]